ONDCP Trial: Early Denies Fraud

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Former Ogilvy & Mather executive Thomas Early in U.S. District Court today admitted to a revenue shortfall on the Office of National Drug Control Policy account and conceded there could have been inaccuracies in the shop’s billings practices on the business.

The former finance director of the WPP Group agency also said he did not instruct any Ogilvy employees to falsely inflate the number of hours they claimed to have worked on the $1 billion ONDCP business.

Early



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in